CAS: 4110-35-4; 3,5-Dinitrobenzonitrile

上下游产品

CAS号121-81-3 3,5-二硝基苯甲酰胺 | CAS号153621-95-5 (3,5-dinitrophe... | CAS号14193-18-1 3,5-二硝基苯甲醛 | CAS号86475-51-6 methoxy(3,5-din... | CAS号98-10-2 苯磺酰胺 | CAS号99-34-3 3,5-二硝基苯甲酸 | CAS号153621-98-8 3-azido-3-(3,5-... | CAS号19019-04-6 2-methoxy-3,5-d... | CAS号2702-58-1 3,5-二硝基苯甲酸甲酯 | CAS号64248-63-1 3,5-二氟苯甲腈 | CAS号10406-92-5 3-amino-5-nitro... | CAS号121-81-3 3,5-二硝基苯甲酰胺 | CAS号33786-93-5 3,5-二氨基苯甲腈 | CAS号33224-19-0 3-甲氧基-5-硝基苯腈 | CAS号110882-60-5 3-氟-5-硝基苯腈 | CAS号90405-50-8 3-(dimethylamin... | CAS号53882-10-3 2-[3-cyano-5-(o...

3,5-二硝基苯甲醛置于氨,碘体系中,用 四氢呋喃,水 作为反应溶剂,化学反应 1.0H,反应生成 3,5-二硝基苯甲腈
参考文献:Iodine-Catalyzed,Efficient,One-Pot Protocol For The Conversion Of Araldehydes Into 5-Aryl-1H-Tetrazoles
标题:Iodine-Catalyzed,Efficient,One-Pot Protocol For The Conversion Of Araldehydes Into 5-Aryl-1H-Tetrazoles
摘要:[image Omitted] An Easy Access To Various 5-Aryl-1H-Tetrazoles By A One-Pot Direct Conversion Of Aldehydes To Tetrazoles Without The Isolation Of The Intermediate Nitriles Using Commercially Available Iodine As A Catalyst Is Described. The Protocol Offers Advantages In Terms Of Good Yields,Mild Reaction Conditions,Short Reaction Times,And Use Of Readily Available Environmentally Compatible Catalyst.
DOI:10.1080/00397911.2010.497593

专利信息

专利号:WO-2016091228-A1
优先权日:2014-12-11
标题 :Substituted phenyltetrazole, its use and pharmaceutical preparation containing it
发明人：ROH JAROSLAV; NEMECEK JAN; HRABALEK ALEXANDR; KLIMESOVA VERA; KARABANOVICH GALINA; PAVEK PETR; SYCHRA PAVEL
权利人:UNIV KARLOVA
摘要:A nitro group-substituted phenyltetrazole of general formula (I) wherein R is selected from the group consisting of: H, C 1 -C 11 alkyl, phenyl- or phenyl- substituted in positions 2, 3, 4 or 5 by one or more electron-acceptor groups and/or by one or more electron-donor groups. These compounds can be prepared by easy synthesis and have significant activity against mycobacteria including their multidrug resistant strains. The invention provides also a pharmaceutical preparation having nitro group-substituted phenyltetrazole of formula (I) as the active ingredient, as well as the use of this nitro group-substituted phenyltetrazole as antituberculosis drug.